Why 10x Genomics, Inc. (TXG) stock fell 12.1% on Monday, November 2, 2026

10x Genomics, Inc. (TXG) closed at $61.63, down 12.10% on Monday, November 2, 2026, on volume of 5,105,101 shares (1.5× its 3-month average); market value about $8.00B.

What happened: primary sources

Events Nexqual found for TXG on Monday, November 2, 2026 or the trading day before (October 30, 2026):

• Nov 2, 2026: SEC 8-K: Director or executive officer change, or pay arrangement source
  Quoted from the filing: “On October 28, 2026, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors of 10x Genomics, Inc. (the "Company") appointed Ansuman Satpathy and Joseph Gilliam to the Board of Directors as Class III directors effective immediately, each with a term expiring at the Company's 2028 annual meeting of stockholders or until his successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal. Dr. Satpathy has served as Associate…”

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on TXG

TXG stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 2, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 10:46 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 10:46 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt